Uptake and localisation of mTHPC (Foscan®) and its 14C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study
2002

Study of mTHPC in Hamster Tumor Model

Sample size: 5 publication Evidence: moderate

Author Information

Author(s): Blant S Andrejevic, Glanzmann T M, Ballini J-P, Wagnières G, van den Bergh H, Monnier P

Primary Institution: Institute of Pathology, CHUV-Hospital, Lausanne, Switzerland

Hypothesis

The study aims to evaluate the pharmacokinetics of mTHPC in different tissues of interest in a hamster tumor model.

Conclusion

The study demonstrated that mTHPC shows significant selectivity for advanced squamous cell carcinoma compared to healthy tissue.

Supporting Evidence

  • mTHPC showed a higher accumulation in advanced squamous cell carcinoma compared to healthy tissue.
  • Significant differences in mTHPC localization were observed between striated and smooth muscle.
  • Three evaluation methods provided consistent results regarding mTHPC distribution.

Takeaway

Researchers injected a special dye into hamsters to see how it spreads in their bodies, especially in tumors, to help improve cancer treatment.

Methodology

The study used in vivo spectrofluorometry, ex vivo fluorescence microscopy, and chemical extraction of 14C-labelled mTHPC to evaluate pharmacokinetics.

Potential Biases

Potential biases in tissue response due to inter-patient variability in drug accumulation.

Limitations

The study may not fully account for environmental factors affecting fluorescence yield.

Participant Demographics

Female Syrian hamsters weighing 140–160 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6600651

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication